➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Merck
Moodys
Medtronic
AstraZeneca

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

CYCLOGYL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Cyclogyl patents expire, and when can generic versions of Cyclogyl launch?

Cyclogyl is a drug marketed by Alcon Labs Inc and is included in three NDAs.

The generic ingredient in CYCLOGYL is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.

Drug patent expirations by year for CYCLOGYL
Drug Prices for CYCLOGYL

See drug prices for CYCLOGYL

Recent Clinical Trials for CYCLOGYL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Eye Disease Prevention and Treatment CenterPhase 4
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePhase 4
Pontificia Universidad Catolica de ChilePhase 4

See all CYCLOGYL clinical trials

US Patents and Regulatory Information for CYCLOGYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs Inc CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084109-001 Approved Prior to Jan 1, 1982 AT RX No Yes   Start Trial   Start Trial   Start Trial
Alcon Labs Inc CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084110-001 Approved Prior to Jan 1, 1982 AT RX No Yes   Start Trial   Start Trial   Start Trial
Alcon Labs Inc CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084108-001 Approved Prior to Jan 1, 1982 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
McKesson
Mallinckrodt
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.